RETRACTED ARTICLE: Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer

Trastuzumab is commonly used in the treatment of human epidermal growth factor receptor-2 positive (HER-2+) breast cancer, but its efficacy is often limited by the emergence of chemoresistance. Recent studies indicate that exosomes act as vehicles for exchange of genetic cargo between heterogeneous...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Death Dis
Autors principals: Han, Mingli, Hu, Jianguo, Lu, Pengwei, Cao, Hui, Yu, Chao, Li, Xiangke, Qian, Xueke, Yang, Xue, Yang, Yunqing, Han, Na, Dou, Dongwei, Zhang, Fan, Ye, Mulin, Yang, Changcheng, Gu, Yuanting, Dong, Huaying
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6976584/
https://ncbi.nlm.nih.gov/pubmed/31969559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-020-2250-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars